GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Net Margin %

Longevity Biomedical (Longevity Biomedical) Net Margin % : 0.00% (As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Longevity Biomedical's Net Income for the six months ended in . 20 was $0.00 Mil. Longevity Biomedical's Revenue for the six months ended in . 20 was $0.00 Mil. Therefore, Longevity Biomedical's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Longevity Biomedical's Net Margin % or its related term are showing as below:


LBIO's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.79
* Ranked among companies with meaningful Net Margin % only.

Longevity Biomedical Net Margin % Historical Data

The historical data trend for Longevity Biomedical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Net Margin % Chart

Longevity Biomedical Annual Data
Trend
Net Margin %

Longevity Biomedical Semi-Annual Data
Net Margin %

Competitive Comparison of Longevity Biomedical's Net Margin %

For the Biotechnology subindustry, Longevity Biomedical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Biomedical's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Net Margin % distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Net Margin % falls into.



Longevity Biomedical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Longevity Biomedical's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Longevity Biomedical's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longevity Biomedical  (NAS:LBIO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Longevity Biomedical Net Margin % Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines